Stage 6: Anxiolytics & Sedative-Hypnotics
Concept 7 of 10
R6.7

Hydroxyzine

H1 antihistamine anxiolytic — non-controlled, useful for acute anxiety, sedation prominent.

Hydroxyzine: non-controlled anxiolytic option for acute anxiety. Rapid onset (~30 min), no abuse liability, no dependence. Sedation is the dominant clinical effect.

Hydroxyzine — Vistaril, Atarax — is a first-generation antihistamine with anxiolytic properties. The mechanism is primarily H1 antagonism, plus 5-HT2A antagonism and alpha-1 effects. The clinical character: rapid onset (~30 minutes), real anxiolytic effect, but heavy sedation and anticholinergic burden.

Drug card
Class
First-generation antihistamine (anxiolytic use)
Mechanism
H1 receptor antagonism + 5-HT2A antagonism + alpha-1 antagonism
Typical dose
25-100 mg every 4-6 hours PRN; can use scheduled
Half-life
~20 hours
FDA indications
Anxiety, pruritus, allergic reactions, nausea, preoperative sedation
Key adverse effects
Sedation (prominent), anticholinergic effects (dry mouth, constipation, blurred vision), cognitive impairment (especially elderly), QTc prolongation at high doses

Useful for: acute anxiety when controlled substance avoided, patients with substance use history, short-term use. Sedation is dominant — not for daytime when alertness needed. Avoid in elderly (anticholinergic burden, fall risk).

Hydroxyzine occupies a specific clinical niche — the patient who needs rapid anxiolytic effect without a controlled substance. The patient with active substance use disorder. The pregnant patient where BZDs are problematic. The patient with a history of BZD misuse where the prescriber prefers to avoid controlled substances. The acutely anxious patient who needs help today but for whom long-term BZD prescribing is inappropriate.

Mechanism in practice

Hydroxyzine is an antihistamine repurposed as an anxiolytic — its sedating H1 blockade provides as-needed anxiety relief without dependence.

Mechanism
H1 antihistamine antagonism
Effect
Sedation and anxiolytic effect
Clinical applications
Effective for acute and as-needed anxiety; a non-controlled alternative to benzodiazepines for situational anxiety.
Mechanism
No GABA-A activity, no abuse potential
Effect
No dependence, no withdrawal, no respiratory depression
Clinical applications
Safe in substance use disorder; usable as-needed without the controlled-substance and dependence concerns of benzodiazepines.
Mechanism
Anticholinergic activity
Effect
Dry mouth, constipation, cognitive effects
Clinical applications
Anticholinergic burden limits use in older adults and with cumulative anticholinergic load.
Mechanism
QTc prolongation
Effect
Risk of QT prolongation, particularly at higher doses
Clinical applications
Caution with other QT-prolonging agents and in cardiac risk.

Mechanism note: Hydroxyzine offers as-needed, non-addictive anxiety relief — a real benzodiazepine alternative for situational anxiety — limited mainly by anticholinergic burden and QTc concern.

The sedation is the dominant clinical feature. At doses of 25-50 mg, most patients are noticeably sedated. For evening or as-needed use, this is often acceptable; for daytime use when alertness matters, it's a limitation. Hydroxyzine is rarely the right choice when the patient needs to drive, work, or stay alert after the dose.

Multi-receptor: H1 (sedation, anti-anxiety), 5-HT2A (anxiety reduction), alpha-1 (orthostasis). Different mechanism from benzodiazepines and buspirone.

Anticholinergic burden is substantial. Dry mouth, constipation, blurred vision, urinary retention, cognitive impairment in the elderly. The Beers Criteria list hydroxyzine as potentially inappropriate in older adults for these reasons. For a young patient with intact cognition, the anticholinergic effects are bothersome but tolerable; for an elderly patient, they can be incapacitating.

Anticholinergic burden: dry mouth, constipation, blurred vision, urinary retention, cognitive impairment. Particularly problematic in elderly — falls, confusion. Use cautiously.

QTc prolongation occurs at higher doses — relevant when combined with other QTc-prolonging agents or in patients with cardiac risk factors.

For situational anxiety in a young adult without controlled-substance options, hydroxyzine is a reasonable choice. For elderly patients, anticholinergic-sensitive patients, or daytime use requiring alertness, alternatives are usually better.

Prescribing reality
Cost
Generic: ~$5-15/month.
Generic status
Generic for decades.
Formulary typical
Tier 1 generic.
Access friction
None.

Prescriber tip: Cheap non-controlled alternative for PRN anxiety. Counsel about sedation and anticholinergic burden — particularly avoid in elderly.

The anchor

Hydroxyzine is the non-controlled antihistamine anxiolytic — rapid onset, useful for acute anxiety especially when controlled substances avoided. Sedation and anticholinergic effects limit broader use.

Prove it

In what clinical scenario might hydroxyzine be preferred over a benzodiazepine for acute anxiety?

This connects to

Locked concepts unlock as you reach them on the path.

Back